William Tillett

4.0k total citations · 1 hit paper
160 papers, 2.1k citations indexed

About

William Tillett is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, William Tillett has authored 160 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Rheumatology, 112 papers in Immunology and 63 papers in Hematology. Recurrent topics in William Tillett's work include Spondyloarthritis Studies and Treatments (131 papers), Psoriasis: Treatment and Pathogenesis (111 papers) and Rheumatoid Arthritis Research and Therapies (76 papers). William Tillett is often cited by papers focused on Spondyloarthritis Studies and Treatments (131 papers), Psoriasis: Treatment and Pathogenesis (111 papers) and Rheumatoid Arthritis Research and Therapies (76 papers). William Tillett collaborates with scholars based in United Kingdom, United States and Canada. William Tillett's co-authors include Neil McHugh, Gavin Shaddick, Philip J. Mease, Eleanor Korendowych, Laura C. Coates, Deepak R. Jadon, Charlotte Cavill, Alexis Ogdie, Oliver FitzGerald and Ying Ying Leung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience and Annals of the Rheumatic Diseases.

In The Last Decade

William Tillett

145 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psoriatic arthritis

2021 190 citations Oliver FitzGerald, Alexis Ogdie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Tillett United Kingdom	23	1.7k	1.4k	915	138	83	160	2.1k
S van der Linden Netherlands	24	3.0k 1.8×	1.4k 1.0×	896 1.0×	65 0.5×	51 0.6×	42	3.6k
Jessica A. Walsh United States	20	972 0.6×	808 0.6×	416 0.5×	99 0.7×	23 0.3×	101	1.3k
Renee Perdok United States	13	1.3k 0.8×	1.0k 0.7×	742 0.8×	161 1.2×	25 0.3×	20	1.8k
Alexander Fraser Ireland	19	1.1k 0.7×	329 0.2×	587 0.6×	24 0.2×	63 0.8×	63	1.6k
Annette Szumski United States	19	896 0.5×	455 0.3×	349 0.4×	45 0.3×	30 0.4×	54	1.1k
Alberto Batticciotto Italy	22	555 0.3×	385 0.3×	209 0.2×	47 0.3×	71 0.9×	66	1.3k
Sigrid Ødegård Norway	17	1.2k 0.7×	295 0.2×	252 0.3×	18 0.1×	112 1.3×	21	1.7k
A.J. Lehman Canada	12	765 0.5×	212 0.1×	225 0.2×	20 0.1×	81 1.0×	30	1.2k
Rafael Cáliz Spain	18	589 0.4×	473 0.3×	166 0.2×	25 0.2×	111 1.3×	60	1.3k
M. Dunn United States	11	320 0.2×	615 0.4×	190 0.2×	237 1.7×	19 0.2×	14	1.2k

Countries citing papers authored by William Tillett

Since Specialization

Citations

This map shows the geographic impact of William Tillett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Tillett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Tillett more than expected).

Fields of papers citing papers by William Tillett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Tillett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Tillett. The network helps show where William Tillett may publish in the future.

Co-authorship network of co-authors of William Tillett

This figure shows the co-authorship network connecting the top 25 collaborators of William Tillett. A scholar is included among the top collaborators of William Tillett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Tillett. William Tillett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Merola, Joseph F., et al.. (2024). Debate at the GRAPPA 2023 Annual Meeting: Should Methotrexate Be the First Systemic Therapy in Psoriatic Disease?. The Journal of Rheumatology. 51(Suppl 2). 58–60. 1 indexed citations

Curtis, Jeffrey R., Atul Deodhar, Enrique R. Soriano, et al.. (2024). Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials. Rheumatology and Therapy. 11(6). 1501–1517. 2 indexed citations

McHugh, Neil, et al.. (2024). Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial. Lara D. Veeken. 64(4). 1750–1759. 1 indexed citations

Watson, Marion, William Tillett, Deepak R. Jadon, et al.. (2024). The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial. Therapeutic Advances in Musculoskeletal Disease. 16. 1759720X241240913–1759720X241240913. 1 indexed citations

Tillett, William, Peter Nash, Laura C. Coates, et al.. (2024). Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies. Therapeutic Advances in Musculoskeletal Disease. 16. 1759720X241288071–1759720X241288071.

Coates, Laura C., et al.. (2024). Qualitative interview study of rheumatology patients’ experiences of COVID-19 shielding to explore the physical and psychological impact and identify associated support needs. BMJ Open. 14(4). e075871–e075871.

McHugh, Neil, Laura Bojke, Laura C. Coates, et al.. (2023). OP0271 INCIDENCE OF PSORIATIC ARTHRITIS AND PREVALENCE OF UNDIAGNOSED CASES IN A UK PRIMARY CARE POPULATION FOLLOWED PROSPECTIVELY FOR 2 YEARS - RESULTS FROM THE TUDOR RANDOMIZED CLINICAL TRIAL. Annals of the Rheumatic Diseases. 82. 178–179.

Tillett, William, Laura C. Coates, Marijn Vis, et al.. (2023). POS1535 EARLY IMPROVEMENT IN 3VAS/4VAS PREDICTS REDUCED RATES OF RADIOGRAPHIC CHANGE IN BIO-NAIVE ACTIVE PSORIATIC ARTHRITIS PATIENTS RECEIVING GUSELKUMAB TREATMENT. Annals of the Rheumatic Diseases. 82. 1131–1132. 2 indexed citations

Helliwell, Philip, Laura C. Coates, Jon Packham, et al.. (2023). The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study. Lara D. Veeken. 63(4). 991–998. 2 indexed citations

10.

Holland, Richard, Ashish Jacob Mathew, Maria Antonietta D’Agostino, et al.. (2022). Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working Group. The Journal of Rheumatology. 49(6 Suppl 1). jrheum.211322–jrheum.211322. 4 indexed citations

11.

Tucker, Laura, Alexander Allen, David Chandler, et al.. (2022). Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Lara D. Veeken. 61(9). 3514–3520. 3 indexed citations

12.

Tillett, William, Oliver FitzGerald, Laura C. Coates, et al.. (2021). Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study. The Journal of Rheumatology. 97. jrheum.201675–jrheum.201675. 9 indexed citations

13.

Rombach, Ines, William Tillett, Deepak R. Jadon, et al.. (2021). Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis—study protocol for the MONITOR-PsA study, a trials within cohorts study design. Trials. 22(1). 185–185. 8 indexed citations

14.

Tillett, William, Oliver FitzGerald, Laura C. Coates, et al.. (2021). Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study. The Journal of Rheumatology. 97. jrheum.201674–jrheum.201674. 17 indexed citations

15.

Leung, Ying Ying, Ana‐Maria Orbai, Alexis Ogdie, et al.. (2020). Appraisal of Candidate Instruments for Assessment of the Physical Function Domain in Patients with Psoriatic Arthritis. The Journal of Rheumatology. 48(1). 58–66. 9 indexed citations

16.

Leung, Ying Ying, William Tillett, Ana‐Maria Orbai, et al.. (2020). The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates. The Journal of Rheumatology. 96. 46–49. 11 indexed citations

17.

Lovell, C. R., Gavin Shaddick, Graham Robinson, et al.. (2019). Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study. The Journal of Rheumatology. 46(9). 1097–1102. 15 indexed citations

18.

Leung, Ying Ying, Ana‐Maria Orbai, Alexis Ogdie, et al.. (2019). The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set. The Journal of Rheumatology. 95. 33–37. 14 indexed citations

19.

Dures, Emma, et al.. (2019). Diagnosis and initial management in psoriatic arthritis: a qualitative study with patients. Rheumatology Advances in Practice. 3(2). rkz022–rkz022. 15 indexed citations

20.

Dures, Emma, et al.. (2017). Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study. Patient. 10(4). 455–462. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact